株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

mヘルス(モバイルヘルス)と在宅モニタリング

mHealth and Home Monitoring - 8th Edition

発行 BERG Insight 商品コード 227122
出版日 ページ情報 英文 280 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.24円で換算しております。

ご注意: Hard Copyにつきましては、航空便送料80ドルが別途かかります。

Back to Top
mヘルス(モバイルヘルス)と在宅モニタリング mHealth and Home Monitoring - 8th Edition
出版日: 2017年02月08日 ページ情報: 英文 280 Pages
概要

2016年末、在宅で医療用コネクテッドモニタリング機器を利用する患者は490万人とされていましたが、この数は38.7%のCAGRで推移し、2021年には2,520万人に達すると予測されています。

当レポートでは、世界のmヘルス(モバイルヘルス)および在宅モニタリング市場の動向と見通しについて調査し、世界の主要地域の医療制度、償還制度、主要なモバイルオペレーターのmヘルス戦略、在宅用コネクテッドモニタリング機器の種類および技術、製品およびソリューションプロバイダーの詳細、市場成長予測、市場成長への各種影響因子の分析などを総合的にまとめています。

エグゼクティブサマリー

第1章 生活習慣病の課題

  • イントロダクション
  • 一般的慢性疾患
  • 医療プロバイダーと償還制度
  • 法規制環境

第2章 mヘルスプラットフォーム

  • mヘルス市場の概要
  • mヘルスコネクティビティソリューション
  • mヘルス治療提供プラットフォーム

第3章 生理学的モニタリングソリューションプロバイダー

  • 医療機器と遠隔モニタリング
  • 心臓律動管理
  • 遠隔ECGモニタリング
  • 血圧モニタリング
  • 凝血モニタリング
  • 睡眠治療モニタリング
  • 家庭用睡眠診断
  • 血中酸素モニタリング
  • 空気循環モニタリング
  • 血糖値モニタリング
  • その他

第4章 投薬、AED(自動体外式除細動器)、 統合モニタリングソリューションプロバイダー

  • テレヘルス/多重パラメータモニタリングソリューション
  • 薬物治療コンプライアンスモニタリング
  • コネクテッドAED

第5章 市場分析・予測

  • 市場予測
  • 収益予測
  • 産業動向・分析
  • 市場成長促進および阻害要因
  • 潜在的な市場刺激因子

用語集

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

How should the mobile industry address the vast business opportunity in wireless healthcare monitoring? The number of home monitoring devices on the global market with integrated cellular connectivity was 4.9 million at the end of 2016 and is forecasted to grow at a CAGR of 38.7 percent in the next five years to reach 25.2 million in 2021. Learn more about how wireless technology can become seamlessly integrated with medical devices in this 280 page in-depth report now in its eighth edition.

Table of Contents

Table of Contents

List of Figures

Executive summary

1. The challenge from welfare diseases

  • 1.1. Introduction
    • 1.1.1. The ageing world population
    • 1.1.2. Metabolic syndrome and lifestyle related diseases
  • 1.2. Common chronic diseases
    • 1.2.1. Cardiac arrhythmia
    • 1.2.2. Ischemic diseases
    • 1.2.3. Hypertension
    • 1.2.4. Sleep apnea
    • 1.2.5. Chronic respiratory diseases
    • 1.2.6. Diabetes
    • 1.2.7. Hyperlipidemia
  • 1.3. Healthcare providers and reimbursement systems
    • 1.3.1. Healthcare in Asia-Pacific
    • 1.3.2. Healthcare in Europe
    • 1.3.3. Healthcare in North America
  • 1.4. Regulatory environment
    • 1.4.1. Regulatory environment in Europe
    • 1.4.2. Regulatory environment in the US
    • 1.4.3. Regulatory environment in other major markets
    • 1.4.4. International standardisation

2. mHealth platforms

  • 2.1. Overview of the mHealth market
    • 2.1.1. mHealth market segments
    • 2.1.2. Connectivity options for medical devices
    • 2.1.3. The mHealth technology value chain
  • 2.2. mHealth connectivity solutions
    • 2.2.1. Apple HealthKit
    • 2.2.2. Ericsson
    • 2.2.3. Google Fit
    • 2.2.4. iHealth (eDevice)
    • 2.2.5. KORE
    • 2.2.6. MedM
    • 2.2.7. Microsoft HealthVault
    • 2.2.8. Orange Healthcare
    • 2.2.9. PTC
    • 2.2.10. Qualcomm Life
    • 2.2.11. Telenor Connexion
    • 2.2.12. Vodafone
  • 2.3. mHealth care delivery platforms
    • 2.3.1. AT&T
    • 2.3.2. BePatient
    • 2.3.3. Domicalis
    • 2.3.4. Exco InTouch
    • 2.3.5. Get Real Health
    • 2.3.6. HealthyCircles (Qualcomm Life)
    • 2.3.7. Medixine
    • 2.3.8. OpenTeleHealth
    • 2.3.9. S3. Group
    • 2.3.10. Tactio Health
    • 2.3.11. Verklizan

3. Physiological monitoring solution providers

  • 3.1. Medical devices and remote monitoring
    • 3.1.1. Medical device revenues by market segment
    • 3.1.2. Overview of the remote patient monitoring market
  • 3.2. Cardiac rhythm management
    • 3.2.1. Overview of the CRM device market
    • 3.2.2. Use cases for CRM monitoring
    • 3.2.3. Remote monitoring solution providers
    • 3.2.4. Biotronik
    • 3.2.5. Boston Scientific
    • 3.2.6. Medtronic
    • 3.2.7. LivaNova
    • 3.2.8. St. Jude Medical
  • 3.3. Remote ECG monitoring
    • 3.3.1. Overview of the remote ECG monitoring device market
    • 3.3.2. Use cases for remote ECG monitoring
    • 3.3.3. Remote monitoring solution providers
    • 3.3.4. Aerotel Medical Systems
    • 3.3.5. AliveCor
    • 3.3.6. BioTelemetry
    • 3.3.7. CardioComm Solutions
    • 3.3.8. LifeWatch
    • 3.3.9. ScottCare
    • 3.3.10. TZ Medical
    • 3.3.11. Zenicor
    • 3.3.12. Preventice Solutions
    • 3.3.13. KHS Medical (LevMed)
  • 3.4. Blood pressure monitoring
    • 3.4.1. Overview of the blood pressure monitoring device market
    • 3.4.2. Use cases for blood pressure monitoring
    • 3.4.3. Remote monitoring solution providers
    • 3.4.4. Omron Healthcare
    • 3.4.5. A&D Medical
    • 3.4.6. Microlife
    • 3.4.7. Rossmax
    • 3.4.8. Sotera Wireless
  • 3.5. Coagulation monitoring
    • 3.5.1. Overview of the coagulation monitoring device market
    • 3.5.2. Use cases for blood coagulation monitoring
    • 3.5.3. Remote monitoring solution providers
    • 3.5.4. Accriva Diagnostics
    • 3.5.5. Alere
    • 3.5.6. CoaguSense
    • 3.5.7. Helena Laboratories
    • 3.5.8. iLine Microsystems
    • 3.5.9. Siemens Healthineers
    • 3.5.10. Roche Diagnostics
  • 3.6. Sleep therapy monitoring
    • 3.6.1. Overview of the sleep therapy device market
    • 3.6.2. Use cases for sleep therapy monitoring
    • 3.6.3. Remote monitoring solution providers
    • 3.6.4. Fisher & Paykel Healthcare
    • 3.6.5. Philips Respironics
    • 3.6.6. ResMed
    • 3.6.7. SRETT
    • 3.6.8. SomnoMed
    • 3.6.9. Löwenstein Medical Technology (Weinmann)
    • 3.6.10. Drive DeVilbiss Healthcare
  • 3.7. Home sleep diagnostics
    • 3.7.1. Overview of the home sleep diagnostics market
    • 3.7.2. Use cases for home sleep diagnostics
    • 3.7.3. Remote monitoring solution providers
    • 3.7.4. Cadwell Laboratories
    • 3.7.5. CareFusion (BD Medical)
    • 3.7.6. Compumedics
    • 3.7.7. Infoscan
    • 3.7.8. Natus Medical
    • 3.7.9. NovaSom
    • 3.7.10. SleepMed
    • 3.7.11. CleveMed
  • 3.8. Blood oxygen monitoring
    • 3.8.1. Overview of the blood oxygen monitoring device market
    • 3.8.2. Use cases for blood oxygen monitoring
    • 3.8.3. Remote monitoring solution providers
    • 3.8.4. ChoiceMMed
    • 3.8.5. Masimo
    • 3.8.6. Nonin Medical
  • 3.9. Air flow monitoring
    • 3.9.1. Overview of the air flow monitoring device market
    • 3.9.2. Use cases for air flow monitoring
    • 3.9.3. Remote monitoring solution providers
    • 3.9.4. Aerocrine (Circassia Pharmaceuticals)
    • 3.9.5. AstraZeneca
    • 3.9.6. Clement Clarke International
    • 3.9.7. Respiri (iSonea)
    • 3.9.8. Medical International Research
    • 3.9.9. Ndd Medizintechnik
    • 3.9.10. nSpire Health
    • 3.9.11. Propeller Health
    • 3.9.12. Sibelmed
    • 3.9.13. Vitalograph
  • 3.10. Glucose level monitoring
    • 3.10.1. Overview of the glucose monitoring device market
    • 3.10.2. Use cases for glucose monitoring
    • 3.10.3. Remote monitoring solution providers
    • 3.10.4. Abbott
    • 3.10.5. Bayer Healthcare
    • 3.10.6. BodyTel
    • 3.10.7. Dexcom
    • 3.10.8. Glooko (Diasend)
    • 3.10.9. Johnson & Johnson
    • 3.10.10. QuiO
    • 3.10.11. Roche Diabetes Care
    • 3.10.12. Telcare
    • 3.10.13. Voluntis
    • 3.10.14. WellDoc
  • 3.11. Other
    • 3.11.1. Implantable medical devices
    • 3.11.2. Home hemodialysis
    • 3.11.3. Telerehabilitation

4. Medication, AED and integrated monitoring solution providers

  • 4.1. Telehealth and multiparameter monitoring solutions
    • 4.1.1. Overview of the telehealth solutions market
    • 4.1.2. Use cases for telehealth solutions
    • 4.1.3. Telehealth solution providers
    • 4.1.4. Aeon Clinical Laboratories (AuthentiDate)
    • 4.1.5. Bosch Healthcare
    • 4.1.6. Care Innovations
    • 4.1.7. H2AD
    • 4.1.8. Honeywell Life Care Solutions
    • 4.1.9. Ideal Life
    • 4.1.10. LindaCare
    • 4.1.11. Medtronic Care Management Services (Cardiocom)
    • 4.1.12. Medvivo
    • 4.1.13. Optum
    • 4.1.14. Philips Hospital to Home
    • 4.1.15. SHL Telemedicine
    • 4.1.16. Telefónica
    • 4.1.17. Tunstall Healthcare Group
    • 4.1.18. Vitaphone
  • 4.2. Medication compliance monitoring
    • 4.2.1. Overview of the medication compliance monitoring market
    • 4.2.2. Use cases for medication compliance monitoring
    • 4.2.3. Compliance monitoring solution providers
    • 4.2.4. Compliance Meds Technologies
    • 4.2.5. DayaMed
    • 4.2.6. Evondos
    • 4.2.7. InRange Systems
    • 4.2.8. Medicpen
    • 4.2.9. Merck
    • 4.2.10. MedSignals
    • 4.2.11. Philips Medido
    • 4.2.12. Proteus Digital Health
  • 4.3. Connected automated external defibrillators
    • 4.3.1. Use cases for defibrillators
    • 4.3.2. Overview of the connected defibrillator market
    • 4.3.3. A.M.I. Italia
    • 4.3.4. AEDMAP
    • 4.3.5. Almas Industries
    • 4.3.6. Cardia International (Skanray Healthcare)
    • 4.3.7. Nihon Kohden
    • 4.3.8. Philips Healthcare
    • 4.3.9. Physio-Control (Stryker)
    • 4.3.10. Pyrescom
    • 4.3.11. Schiller
    • 4.3.12. Spacelabs Healthcare
    • 4.3.13. Zoll

5. Market analysis and forecasts

  • 5.1. Market forecasts
    • 5.1.1. Cardiac rhythm management
    • 5.1.2. Sleep therapy
    • 5.1.3. Telehealth and multiparameter monitoring
    • 5.1.4. ECG monitoring
    • 5.1.5. Glucose level monitoring
    • 5.1.6. Medication compliance monitoring
    • 5.1.7. Other medical devices
  • 5.2. Revenue forecasts
    • 5.2.1. Medical monitoring devices
    • 5.2.2. mHealth connectivity solutions
    • 5.2.3. Care delivery platforms
    • 5.2.4. mHealth care programs
  • 5.3. Industry trends and analysis
    • 5.3.1. Connectivity strong trend when new players enter the market
    • 5.3.2. Major pharmaceutical companies prepare large-scale rollouts
    • 5.3.3. Consumerisation of medical-grade mHealth devices and apps
    • 5.3.4. BYOD is becoming a popular and viable option
    • 5.3.5. Digitalisation of PSTN networks in the works
    • 5.3.6. Modularization of the value chain as the market matures
    • 5.3.7. Automated external defibrillators are getting connected
    • 5.3.8. The data war has started
  • 5.4. Market drivers and barriers
    • 5.4.1. An ageing population is raising medical costs
    • 5.4.2. Obesity epidemic and Increasing welfare disease prevalence
    • 5.4.3. Increased focus on disease prevention
    • 5.4.4. Substitutes to medical monitoring
    • 5.4.5. A slowly changing industry
    • 5.4.6. Alignment of financial incentives
  • 5.5. Potential market catalysts
    • 5.5.1. Increased monitoring during clinical trials
    • 5.5.2. Incentives from insurance companies and payers
    • 5.5.3. National health systems support remote monitoring
    • 5.5.4. New clinical evidence on cost effectiveness
    • 5.5.5. Non-prescribed monitoring and healthcare consumerism

Glossary

List of Figures

  • Figure 1.1: Population by age group (EU, North America and Japan 2015-2030)
  • Figure 1.2: Direct and indirect costs of chronic welfare diseases in the US and EU
  • Figure 1.3: Number of people suffering from chronic welfare diseases (EU/US 2008)
  • Figure 1.4: Percentage of population diagnosed with chronic welfare diseases
  • Figure 1.5: Total and per capita healthcare spending by country (2013)
  • Figure 1.6: Healthcare expenditure per capita by country (World 2014)
  • Figure 1.7: Share of population covered by private health insurance by country
  • Figure 1.8: Healthcare spending by type of service and product (US 2013)
  • Figure 2.1: mHealth market segments
  • Figure 2.2: Connected medical devices and the provision of care
  • Figure 2.3: Overview of the mHealth technology value chain
  • Figure 2.4: Main focus areas of mHealth connectivity solution providers
  • Figure 2.5: Apps that can be connected to Google Fit
  • Figure 2.6: HealthGO+ and HealthGO Mini by eDevice
  • Figure 2.7: MedM mobile applications
  • Figure 2.8: Examples of HealthVault-certified devices
  • Figure 2.9: Examples of mHealth software products and platforms
  • Figure 2.10: BP eHealth Platform patient dashboard
  • Figure 2.11: Medixine Suite
  • Figure 2.12: The core modules of the TactioRPM mobile app
  • Figure 3.1: Medical device market revenues by segment (World 2015-2021)
  • Figure 3.2: Connected medical devices by segment (World 2016)
  • Figure 3.3: Implantable cardiac rhythm management vendor market shares (2015)
  • Figure 3.4: Examples of implantable CRM devices
  • Figure 3.5: Examples of remote monitoring devices
  • Figure 3.6: Market shares for remote monitoring of CRM implants (2016)
  • Figure 3.7: CardioMessenger devices
  • Figure 3.8: Latitude NXT Wave wireless communicator
  • Figure 3.9: The Merlin.net interface and Merlin@Home transmitter
  • Figure 3.10: The Infinity DBS System
  • Figure 3.11: MCT sensor and monitor from CardioNet
  • Figure 3.12: Implantable loop recorder from Medtronic
  • Figure 3.13: AliveCor Mobile ECG third generation
  • Figure 3.14: AliveCor's AliveECG app
  • Figure 3.15: HeartCheck devices from CardioComm Solutions
  • Figure 3.16: Blood pressure monitor from Omron Healthcare
  • Figure 3.17: Sleep therapy vendor market shares (2015)
  • Figure 3.18: ResMed S9 CPAP device with FX Series masks
  • Figure 3.19: Connected sleep therapy solutions by vendor (2016)
  • Figure 3.20: DreamMapper mobile application
  • Figure 3.21: ResMed myAir
  • Figure 3.22: SRETT T4P and TeleOx
  • Figure 3.23: SomnoDent Fusion
  • Figure 3.24: The prisma25S sleep therapy device from Löwenstein Medical Technology
  • Figure 3.25: Examples of home sleep diagnostics companies and products
  • Figure 3.26: iSpO2 and MightySat device and application
  • Figure 3.27: Turbu+ inhaler sensor and app
  • Figure 3.28: iSonea's device and asthma management app
  • Figure 3.29: Propeller Health's asthma management app and inhaler sensor
  • Figure 3.30: Blood glucose meter vendor market shares (2015)
  • Figure 3.31: CGM and insulin delivery system vendor market shares (2015)
  • Figure 3.32: Medication usage by diabetes patients (US 2011)
  • Figure 3.33: Glucose meters from LifeScan and Roche
  • Figure 3.34: Dexcom G4 CGM system
  • Figure 3.35: Asante Pearl insulin pump
  • Figure 3.36: Examples of connected blood glucose meters
  • Figure 3.37: Examples of connected CGM and insulin pump systems
  • Figure 3.38: FreeStyle Libre Flash glucose meter
  • Figure 3.39: Dexcom G5 app and transmitter
  • Figure 3.40: Roche Accu-Chek Connect app
  • Figure 3.41: WellDoc BlueStar
  • Figure 4.1: Overview of the telehealth and multiparameter monitoring landscape
  • Figure 4.2: Installed base of telehealth hubs by region (2016)
  • Figure 4.3: Telehealth hub vendor market shares (2016)
  • Figure 4.4: The Health Harmony solution
  • Figure 4.5: The Twitoo telehealth hub
  • Figure 4.6: The Honeywell Genesis DM telehealth monitor with peripherals
  • Figure 4.7: eCareCompanion and eCareCoordinator
  • Figure 4.8: Compliance monitoring solution form factors
  • Figure 4.9: The CleverCap dispenser
  • Figure 4.10: The DayaMed MedPod
  • Figure 4.11: The Evondos E300 Automatic Medicine Dispenser
  • Figure 4.12: The EMMA medication management system
  • Figure 4.13: The Easypod injector and the Easypod connect transmitter
  • Figure 4.14: The Philips Medido medication dispenser
  • Figure 4.15: AEDMAP CONNECT - a connected cabinet for AEDs
  • Figure 4.16: The DOC defibrillator from Almas Industries
  • Figure 5.1: Connected home medical monitoring devices (World 2015-2021)
  • Figure 5.2: Connected home medical monitoring devices by region (World 2015-2021)
  • Figure 5.3: Connected cardiac rhythm management devices (World 2015-2021)
  • Figure 5.4: Connected sleep therapy devices (World 2015-2021)
  • Figure 5.5: Telehealth hubs (World 2015-2021)
  • Figure 5.6: Connected ECG monitoring devices (World 2015-2021)
  • Figure 5.7: Connected glucose monitoring devices (World 2015-2021)
  • Figure 5.8: Connected medication monitoring solutions (World 2015-2021)
  • Figure 5.9: Other connected medical devices (World 2015-2021)
  • Figure 5.10: Remote patient monitoring revenues (World 2015-2021)
  • Figure 5.11: Connected medical device revenues (World 2015-2021)
  • Figure 5.12: mHealth connectivity solution revenues (World 2015-2021)
  • Figure 5.13: Care delivery platform revenues (World 2015-2021)
  • Figure 5.14: Monitoring service revenues (World 2015-2021)
  • Figure 5.15: New players enter the connected care market
  • Figure 5.16: Examples of landmark events for healthcare consumerisation
Back to Top